Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
NCT ID: NCT02914730
Last Updated: 2018-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2016-09-30
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Structured Insulin Order
NCT01130558
A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections
NCT01045954
Connected Pens for Diabetes Study
NCT03830216
The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mellitus
NCT04120974
Dose Response Study of Transdermal Human Insulin in Patients
NCT05159453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 2 insulin injections
* Age 18-35 or older than 65 years
* Use of glargine insulin as basal insulin
* Stable insulin doses for past 3 months
Exclusion Criteria
* Visual or cognitive impairment with inability to self-administer insulin
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Joslin Diabetes Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Medha Munshi
Director of Joslin Geriatric Diabetes Programs Beth Israel Deaconess Medical Center Associate Professor of Medicine, Harvard Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Joslin DIabetes Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Munshi MN, Slyne C, Greenberg JM, Greaves T, Lee A, Carl S, Atakov-Castillo A, Toschi E. Nonadherence to Insulin Therapy Detected by Bluetooth-Enabled Pen Cap Is Associated With Poor Glycemic Control. Diabetes Care. 2019 Jun;42(6):1129-1131. doi: 10.2337/dc18-1631. Epub 2019 Mar 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHS #2015-47
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.